Scatter factor binds to thrombospondin and other extracellular matrix components

Area of Science:

• Molecular Biology
• Cancer Research
• Extracellular Matrix Biology

Background:

• Scatter factor (SF) is an angiogenic growth factor implicated in carcinoma cell motility and invasion.
• SF is present in the extracellular matrix (ECM) of breast cancers, potentially promoting tumor invasion and angiogenesis.

Purpose of the Study:

• To investigate the mechanisms by which SF incorporates into the breast cancer ECM.
• To identify specific ECM components that bind SF and characterize the binding affinities.
• To elucidate the role of SF-ECM interactions in tumor angiogenesis.

Main Methods:

• Solid-phase binding assays utilizing SF enzyme-linked immunosorbent assay (ELISA) to study SF binding to various ECM components.
• Binding competition assays to determine the relative affinities of SF for different ECM molecules.
• Analysis of SF binding to ECMs secreted by human breast carcinoma cell lines.
• Inhibition assays using antibodies against ECM components.
• In vitro and in vivo angiogenesis assays (endothelial cell chemotaxis, rat cornea neovascularization assay).

Main Results:

• SF binds to multiple ECM molecules, with highest capacities for thrombospondin-1 (TSP-1), fibronectin (Fn), and heparan sulfate proteoglycan.
• SF exhibits high-affinity binding to TSP-1, which appears to mediate SF's incorporation into breast cancer matrices.
• TSP-1 significantly inhibits SF-induced angiogenesis and endothelial cell chemotaxis, suggesting a regulatory role in tumor vascularization.

Conclusions:

• SF interacts with diverse ECM components, with a notable high-affinity interaction with TSP-1.
• The SF-TSP-1 interaction is a key mechanism for SF sequestration within the breast cancer ECM.
• This interaction modulates angiogenesis, highlighting its potential as a therapeutic target in cancer.